Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials / Sanofi

Clinicaltrial registered17 Nov 2026

Sanofi

17 Nov 2026: Trial registered · Study of Hexaxim Compared With Pentaxim Administered With a Monovalent Hepatitis B Vaccine in Healthy Chinese Infants.. Recorded in the ClinicalTrials.gov (US National Library of Medicine).

View the source record

Posted
17 Nov 2026
Title
Study of Hexaxim Compared With Pentaxim Administered With a Monovalent Hepatitis B Vaccine in Healthy Chinese Infants.
Conditions
Haemophilus Influenzae Type b Immunisation, Hepatitis B Immunisation, Polio Immunization, Pertussis Immunisation
Phase
Phase 3
Study Type
Interventional
Status
Not Yet Recruiting
Reference
NCT07941622
What this signal means

A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at Sanofi

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.

Start free

Across AOS Research

Other records for Sanofi in our registers.

Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.